Costa LG - Search Results

1

Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders.

Costa LG, Cole TB, Dao K, Chang YC, Coburn J, Garrick JM. Costa LG, et al. Pharmacol Ther. 2020 Jun;210:107523. doi: 10.1016/j.pharmthera.2020.107523. Epub 2020 Mar 9. Pharmacol Ther. 2020. PMID: 32165138 Free PMC article. Review.

2

Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.

Balduini W, Costa LG. Balduini W, et al. Among authors: costa lg. J Pharmacol Exp Ther. 1989 Aug;250(2):541-7. J Pharmacol Exp Ther. 1989. PMID: 2547937

3

Pharmacogenomic considerations of the paraoxonase polymorphisms.

Furlong CE, Cole TB, Jarvik GP, Costa LG. Furlong CE, et al. Among authors: costa lg. Pharmacogenomics. 2002 May;3(3):341-8. doi: 10.1517/14622416.3.3.341. Pharmacogenomics. 2002. PMID: 12052142 Review.

4

Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.

Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. Costa LG, et al. Biomarkers. 2003 Jan-Feb;8(1):1-12. doi: 10.1080/13547500210148315. Biomarkers. 2003. PMID: 12519632 Review.

5

Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism.

Costa LG, Cole TB, Jarvik GP, Furlong CE. Costa LG, et al. Annu Rev Med. 2003;54:371-92. doi: 10.1146/annurev.med.54.101601.152421. Epub 2001 Dec 3. Annu Rev Med. 2003. PMID: 12525679 Review.

6

Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates.

Costa LG, Cole TB, Furlong CE. Costa LG, et al. J Toxicol Clin Toxicol. 2003;41(1):37-45. doi: 10.1081/clt-120018269. J Toxicol Clin Toxicol. 2003. PMID: 12645966 Review.

7

Expression of human paraoxonase (PON1) during development.

Cole TB, Jampsa RL, Walter BJ, Arndt TL, Richter RJ, Shih DM, Tward A, Lusis AJ, Jack RM, Costa LG, Furlong CE. Cole TB, et al. Among authors: costa lg. Pharmacogenetics. 2003 Jun;13(6):357-64. doi: 10.1097/00008571-200306000-00007. Pharmacogenetics. 2003. PMID: 12777966

8

Developmental neuropathology of environmental agents.

Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OP. Costa LG, et al. Annu Rev Pharmacol Toxicol. 2004;44:87-110. doi: 10.1146/annurev.pharmtox.44.101802.121424. Annu Rev Pharmacol Toxicol. 2004. PMID: 14744240 Free PMC article. Review.

9

Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.

Costa LG, Cole TB, Vitalone A, Furlong CE. Costa LG, et al. Clin Chim Acta. 2005 Feb;352(1-2):37-47. doi: 10.1016/j.cccn.2004.09.019. Clin Chim Acta. 2005. PMID: 15653099 Review.

10

Modulation of paraoxonase (PON1) activity.

Costa LG, Vitalone A, Cole TB, Furlong CE. Costa LG, et al. Biochem Pharmacol. 2005 Feb 15;69(4):541-50. doi: 10.1016/j.bcp.2004.08.027. Biochem Pharmacol. 2005. PMID: 15670573 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page